Melensurf Injection

Adult dosage

For individuals requiring a daily baseline amount of trace elements, or with moderately increased daily requirements, administer 10mL per day. This medication must be diluted before administration.

Children's dosage

For children over 15kg in weight, administer 0.1mL per kg of body weight per day. This medication must be diluted before administration.

This medication must be diluted before administration and should be used according to the physician's instructions. It should not be used in patients with allergies to this medication or its components, those with obstructed bile ducts, zinc toxicity, iron overload or problems with iron utilization, patients with copper accumulation, and those with high blood levels of the trace elements included in this medication. Patients with abnormal bile or kidney function that significantly affects trace element excretion, liver function impairment, those receiving intravenous nutrition for more than four weeks, and neonates and children should receive this medication with caution, and liver function and trace element levels should be regularly monitored. No adverse reactions due to the trace elements in this medication have been reported; however, inflammation within blood vessels may occur when administered with glucose injection, and local allergic reactions to iodine may appear when used topically. When administered continuously for more than four weeks, liver function and manganese levels should be checked, and if manganese levels increase, administration should be discontinued. In patients with impaired kidney or liver function, there is a risk of accumulation of trace elements in the body; therefore, caution is necessary. Patients with iron overload may experience side effects due to serum iron accumulation, so caution is advised. In case of deficiency of specific trace elements, selective supplementation should be performed. There is insufficient data on the safety of this medication during pregnancy; thus, it should only be used in pregnant women or those who could become pregnant when the benefits outweigh the risks. Safety for breastfeeding individuals has also not been established, so during lactation, breastfeeding should be suspended or the use of medication should be discontinued. This medication can be added to glucose injection; however, it should not be administered with other solutions that are unverified as there is a risk of incompatibility. Dilution should be performed in an aseptic condition, and the diluted solution should be used immediately. To prevent contamination, the diluted solution should be administered within 24 hours, and any remaining solution should be discarded.

Mild side effects

Superficial thrombophlebitis was observed when this medication was added to glucose injection. Local application may cause hypersensitivity reactions to iodine. However, these reactions were not observed when administered intravenously at the recommended dosage.

This medication should be stored in a sealed container to prevent air and moisture penetration, at a cool place between 1 to 25 degrees Celsius. Storing it this way can maintain the efficacy of the medication for a longer time.

Appearance

An almost colorless transparent solution contained in a colorless transparent vial.

Package unit

10mL/vial X 10